Literature DB >> 19933346

Construction of a nontoxigenic Clostridium botulinum strain for food challenge studies.

Marite Bradshaw1, Kristin M Marshall, John T Heap, William H Tepp, Nigel P Minton, Eric A Johnson.   

Abstract

Clostridium botulinum produces the most poisonous natural toxin known and is a perennial concern to the food industry and to regulatory agencies due to the potential threat of food-borne botulism. To ensure the botulinal safety of foods, rigorous food challenge testing to validate food-processing conditions and food formulations has been routinely performed. Detection of the botulinum neurotoxin is performed by using a mouse bioassay and/or in vitro assays. There has been considerable interest by the food industry and regulatory agencies in minimizing or even replacing the use of animals in these challenge studies. In addition, due to stringent select-agent regulations, the testing of various foods using toxigenic C. botulinum strains requires facilities and personnel that are certified for work with this organism. For this purpose we propose to generate sets of nontoxigenic C. botulinum strains from proteolytic and nonproteolytic groups that differ from the wild-type strains only by their inability to produce botulinum neurotoxin. In this initial study we describe the generation of a nontoxigenic mutant of C. botulinum strain 62A using the ClosTron mutagenesis system by inserting a group II intron into the botulinum neurotoxin type A gene (bont/A). The mutant clones were nontoxigenic as determined by Western blots and mouse bioassays but showed physiological characteristics, including growth properties and sporulation, that were similar to those of the parent strain in laboratory media. Additional studies will be required to evaluate comparable characteristics in various food matrices. The availability of suitable nontoxigenic C. botulinum strains for food challenge studies will be beneficial for enhancing the botulinal safety of foods as well as increasing the biosafety of workers and may eliminate the use of laboratory animals.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19933346      PMCID: PMC2805223          DOI: 10.1128/AEM.02005-09

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  22 in total

1.  Purification of Clostridium botulinum type A neurotoxin.

Authors:  C J Malizio; M C Goodnough; E A Johnson
Journal:  Methods Mol Biol       Date:  2000

2.  Group II introns as controllable gene targeting vectors for genetic manipulation of bacteria.

Authors:  M Karberg; H Guo; J Zhong; R Coon; J Perutka; A M Lambowitz
Journal:  Nat Biotechnol       Date:  2001-12       Impact factor: 54.908

3.  Targeted and random bacterial gene disruption using a group II intron (targetron) vector containing a retrotransposition-activated selectable marker.

Authors:  Jin Zhong; Michael Karberg; Alan M Lambowitz
Journal:  Nucleic Acids Res       Date:  2003-03-15       Impact factor: 16.971

4.  Antibotulinal activity of process cheese ingredients.

Authors:  Kathleen A Glass; Eric A Johnson
Journal:  J Food Prot       Date:  2004-08       Impact factor: 2.077

Review 5.  Mobile group II introns.

Authors:  Alan M Lambowitz; Steven Zimmerly
Journal:  Annu Rev Genet       Date:  2004       Impact factor: 16.830

6.  A modular system for Clostridium shuttle plasmids.

Authors:  John T Heap; Oliver J Pennington; Stephen T Cartman; Nigel P Minton
Journal:  J Microbiol Methods       Date:  2009-05-13       Impact factor: 2.363

Review 7.  Molecular analysis of the microbial food safety implications of food reformulations for improved health.

Authors:  Roy D Sleator; Colin Hill
Journal:  Foodborne Pathog Dis       Date:  2008-08       Impact factor: 3.171

8.  The ClosTron: Mutagenesis in Clostridium refined and streamlined.

Authors:  John T Heap; Sarah A Kuehne; Muhammad Ehsaan; Stephen T Cartman; Clare M Cooksley; Jamie C Scott; Nigel P Minton
Journal:  J Microbiol Methods       Date:  2009-11-03       Impact factor: 2.363

9.  The ClosTron: a universal gene knock-out system for the genus Clostridium.

Authors:  John T Heap; Oliver J Pennington; Stephen T Cartman; Glen P Carter; Nigel P Minton
Journal:  J Microbiol Methods       Date:  2007-06-18       Impact factor: 2.363

10.  Independent evolution of neurotoxin and flagellar genetic loci in proteolytic Clostridium botulinum.

Authors:  Andrew T Carter; Catherine J Paul; David R Mason; Susan M Twine; Mark J Alston; Susan M Logan; John W Austin; Michael W Peck
Journal:  BMC Genomics       Date:  2009-03-19       Impact factor: 3.969

View more
  11 in total

1.  Holotoxin Activity of Botulinum Neurotoxin Subtype A4 Originating from a Nontoxigenic Clostridium botulinum Expression System.

Authors:  Marite Bradshaw; William H Tepp; Regina C M Whitemarsh; Sabine Pellett; Eric A Johnson
Journal:  Appl Environ Microbiol       Date:  2014-09-19       Impact factor: 4.792

2.  Involvement of Clostridium botulinum ATCC 3502 sigma factor K in early-stage sporulation.

Authors:  David G Kirk; Elias Dahlsten; Zhen Zhang; Hannu Korkeala; Miia Lindström
Journal:  Appl Environ Microbiol       Date:  2012-04-27       Impact factor: 4.792

3.  Construction of Nontoxigenic Mutants of Nonproteolytic Clostridium botulinum NCTC 11219 by Insertional Mutagenesis and Gene Replacement.

Authors:  Charlien Clauwers; Kristof Vanoirbeek; Laurence Delbrassinne; Chris W Michiels
Journal:  Appl Environ Microbiol       Date:  2016-05-02       Impact factor: 4.792

4.  Characterization of botulinum neurotoxin A subtypes 1 through 5 by investigation of activities in mice, in neuronal cell cultures, and in vitro.

Authors:  Regina C M Whitemarsh; William H Tepp; Marite Bradshaw; Guangyun Lin; Christina L Pier; Jacob M Scherf; Eric A Johnson; Sabine Pellett
Journal:  Infect Immun       Date:  2013-08-05       Impact factor: 3.441

5.  Ultrasound-mediated DNA transformation in thermophilic gram-positive anaerobes.

Authors:  Lu Lin; Houhui Song; Yuetong Ji; Zhili He; Yunting Pu; Jizhong Zhou; Jian Xu
Journal:  PLoS One       Date:  2010-09-04       Impact factor: 3.240

Review 6.  Towards new uses of botulinum toxin as a novel therapeutic tool.

Authors:  Andy Pickett; Karen Perrow
Journal:  Toxins (Basel)       Date:  2011-01-12       Impact factor: 4.546

7.  Biotechnological applications of mobile group II introns and their reverse transcriptases: gene targeting, RNA-seq, and non-coding RNA analysis.

Authors:  Peter J Enyeart; Georg Mohr; Andrew D Ellington; Alan M Lambowitz
Journal:  Mob DNA       Date:  2014-01-13

8.  Purification and Characterization of Botulinum Neurotoxin FA from a Genetically Modified Clostridium botulinum Strain.

Authors:  Sabine Pellett; William H Tepp; Marite Bradshaw; Suzanne R Kalb; Janet K Dykes; Guangyun Lin; Erin M Nawrocki; Christina L Pier; John R Barr; Susan E Maslanka; Eric A Johnson
Journal:  mSphere       Date:  2016-02-24       Impact factor: 4.389

9.  Persistence of botulinum neurotoxin a subtypes 1-5 in primary rat spinal cord cells.

Authors:  Regina Clare Meyer Whitemarsh; William Howard Tepp; Eric Arthur Johnson; Sabine Pellett
Journal:  PLoS One       Date:  2014-02-27       Impact factor: 3.240

10.  Posttranslational Regulation of Botulinum Neurotoxin Production in Clostridium botulinum Hall A-hyper.

Authors:  Heather N'te Inzalaco; William H Tepp; Chase Fredrick; Marite Bradshaw; Eric A Johnson; Sabine Pellett
Journal:  mSphere       Date:  2021-08-04       Impact factor: 4.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.